Medicare Enrolled
Dr. Amish Parikh, M.D.
Cardiovascular Disease · Maitland, FL
Practice pattern: Remote Monitoring— Significant remote device monitoring activity
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Parikh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parikh? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parikh
Dr. Amish Parikh is a cardiovascular disease in Maitland, FL, with 19 years in practice. Based on federal Medicare data, Dr. Parikh performed 17,876 Medicare services across 6,965 unique beneficiaries.
Between the years covered by Open Payments, Dr. Parikh received a total of $172,064 from 48 pharmaceutical and/or device companies across 488 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parikh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in FL$ $172,064 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,876
Medicare services
Top 2% in FL for cardiovascular disease
6,965
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~941 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 2,581 | $0 | $1 |
| Remote patient monitoring management, 20 min/month | 2,565 | $38 | $67 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 2,495 | $31 | $55 |
| Office visit, established patient (30-39 min) | 1,730 | $92 | $175 |
| Remote patient monitoring device, 30 days | 1,569 | $38 | $66 |
| Regadenoson injection (Lexiscan) for heart stress test | 627 | $41 | $75 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 626 | $14 | $26 |
| Echocardiogram, transthoracic | 556 | $136 | $252 |
| Electrocardiogram (EKG), 12-lead | 544 | $11 | $20 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 522 | $358 | $628 |
| Nursing facility visit, moderate complexity | 502 | $82 | $147 |
| Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | 335 | $105 | $185 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 326 | $48 | $96 |
| Home visit, established patient, moderate complexity | 320 | $90 | $149 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 314 | $333 | $586 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 186 | $20 | $35 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 185 | $625 | $1,090 |
| Remote pacemaker/defibrillator monitoring, 90 days | 185 | $17 | $30 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 178 | $28 | $75 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 177 | $50 | $98 |
| New patient office visit (45-59 min) | 171 | $117 | $230 |
| Remote pacemaker monitoring, 90 days | 159 | $23 | $42 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 150 | $90 | $125 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 118 | $20 | $76 |
| Office visit, established patient, complex (40-54 min) | 104 | $135 | $245 |
| Programming of dual lead pacemaker system | 93 | $56 | $108 |
| Ultrasound of both sides of head and neck blood flow | 84 | $85 | $176 |
| Interrogation device evaluation (in person) carotid sinus baroreflex activation system, with programming | 64 | $58 | $101 |
| Evaluation of implantable heart and blood vessel monitoring system | 64 | $35 | $73 |
| Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 44 | $142 | $250 |
| Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | 37 | $102 | $143 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 33 | $124 | $236 |
| Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | 32 | $138 | $207 |
| Ultrasound of leg arteries or artery grafts | 31 | $126 | $252 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 26 | $29 | $51 |
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 26 | $88 | $211 |
| Test to measure rate of airflow | 21 | $30 | $52 |
| Test for exercise-induced heart and lung stress | 21 | $121 | $208 |
| New patient office visit, complex (60-74 min) | 21 | $168 | $305 |
| Programming of single lead pacemaker system | 18 | $44 | $92 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 13 | $8 | $25 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 12 | $17 | $35 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $104 | $191 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.9% high complexity
22.4% medium
71.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$172,064
Total received (2018-2024)
Avg $24,581/year across 7 years
Top 2% in FL for cardiovascular disease
48
Companies
488
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$138,173 (80.3%)
Scientific / Research
Research funding and grants
$22,143 (12.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,658 (3.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,089 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$9,628
2023$24,213
2022$25,702
2021$26,292
2020$16,375
2019$42,729
2018$27,125
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$101,480
BIOTRONIK INC.
$23,542
Lilly USA, LLC
$22,804
Novartis Pharmaceuticals Corporation
$19,663
Boston Scientific Corporation
$444
Merck Sharp & Dohme LLC
$429
Janssen Pharmaceuticals, Inc
$396
Amgen Inc.
$341
SANOFI-AVENTIS U.S. LLC
$320
CVRx, Inc.
$319
PFIZER INC.
$272
Alnylam Pharmaceuticals Inc.
$185
Relypsa, Inc.
$136
Novo Nordisk Inc
$126
Gilead Sciences, Inc.
$92
Esperion Therapeutics, Inc.
$91
Impulse Dynamics (USA) Inc.
$90
Astellas Pharma US Inc
$90
BOSTON SCIENTIFIC CORPORATION
$79
AstraZeneca Pharmaceuticals LP
$78
Allergan Inc.
$77
Merck Sharp & Dohme Corporation
$77
Edwards Lifesciences Corporation
$73
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$68
E.R. Squibb & Sons, L.L.C.
$66
Regeneron Healthcare Solutions, Inc.
$66
Lundbeck LLC
$56
Ambu Inc.
$56
ARBOR PHARMACEUTICALS, INC.
$54
Bardy Diagnostics, Inc.
$44
Amarin Pharma Inc.
$43
Kowa Pharmaceuticals America, Inc.
$38
ABIOMED
$31
Kiniksa Pharmaceuticals International, plc
$30
Bayer HealthCare Pharmaceuticals Inc.
$30
Arbor Pharmaceuticals, Inc.
$29
Abbott Laboratories
$29
ATRICURE, INC.
$27
United Therapeutics Corporation
$26
ARALEZ PHARMACEUTICALS US INC.
$25
SCPHARMACEUTICALS INC.
$24
iRhythm Technologies, Inc.
$21
Lexicon Pharmaceuticals, Inc.
$20
Actelion Pharmaceuticals US, Inc.
$20
Medtronic, Inc.
$17
Adhera Therapeutics, Inc.
$16
G Medical Diagnostic Services, Inc.
$14
Tactile Systems Technology Inc
$11
Top 3 companies account for 85.9% of total payments
Associated products mentioned in payments ›
Acticor 7 VR-T DX · Adempas · Arcalyst · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · Baylis Medical Company Radiofrequency Puncture Generator · BioMonitor · CAMZYOS · CHANTIX · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · FUROSCIX · GILENYA · Impella · Inpefa · JARDIANCE · Kerendia · LEQVIO · LINZESS · LifeVest · Livalo · MULTAQ · Mitra Clip system · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · PRESTALIA · Repatha · Rivacor · SYNERGY ABLATION SYSTEM · TYVASO · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · XARELTO · ZONTIVITY · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for cardiovascular disease in FL.
Equivalent to $963 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
188
Per 100K population
13.1
County median income
$77,011
Nearest hospital
ADVENTHEALTH ORLANDO
5.3 mi
5.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Parikh is a remote monitoring specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (speaking/promotional, top 2%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Parikh experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Based on Medicare claims data, Dr. Parikh performed 2,581 injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parikh receive payments from pharmaceutical companies?
Yes. Dr. Parikh received a total of $172,064 from 48 companies across 488 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parikh's costs compare to other cardiovascular diseases in Maitland?
Dr. Parikh's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parikh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Maitland
Browse cardiovascular diseases in Maitland ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology